Copayment vouchers for P2Y12 inhibitors modestly improved the likelihood that patients would continue taking the guideline-recommended medications for one year after myocardial infarction, according to a study published in JAMA. However, patients supplied with this financial assistance didn’t see a subsequent improvement in clinical outcomes.
ST-segment elevation myocardial infarction (STEMI) survivors covered by Medicaid have lower rates of revascularization and higher rates of in-hospital mortality than their counterparts with private insurance, according to a study published in Circulation: Cardiovascular Quality and Outcomes.
In the past year bone broth—the result of simmering animal bones with herbs and vegetables for anywhere between 20 minutes and 20 hours—has been lauded as a superfood, promoted as a Hollywood diet and linked to benefits like better gut health and stronger joints. Now, research out of Spain is proving at least some of those claims are true.
Older adults living in long-term care facilities experienced a similar risk of mortality and cardiovascular hospitalizations regardless of whether they were taking intensive or more moderate doses of statins, a retrospective study found.
Sleeping less than six hours a night or experiencing poor-quality rest has been independently linked to an increased risk of subclinical multiterritory atherosclerosis, a team of Spanish researchers reported in the Journal of the American College of Cardiology Jan. 14.
Medtronic announced on Jan. 15 the launch of a mobile app that connects four of the company’s pacemakers to patients’ smartphones and tablets, removing the need for bedside monitors or other remote monitoring equipment.
High retail prices for diabetes test strips are driving a “gray market” in the U.S. as an increasing number of uninsured diabetics struggle to afford something they need as often as 10 times a day, the New York Times reports.
Rivaroxaban failed to reduce the rate of early graft failure following coronary artery bypass graft (CABG) surgery compared to aspirin monotherapy, researchers reported in a substudy of the COMPASS trial published Jan. 14 in the Journal of the American College of Cardiology.
A study published online in the American Journal of Epidemiology Jan. 14 suggests any physical movement, whether it’s short, long, intense or mild, counteracts the negative cardiovascular effects of sitting for long periods.
Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.